Commercialization

STOCKHOLM, Feb. 23, 2023 /PRNewswire/ -- Xspray Pharma AB, (NASDAQ Stockholm: XSPRAY) has signed an agreement with EVERSANA® to support the U.S. launch and commercialization of the company's first innovative cancer therapy Dasynoc for the…

<!-- Name:DistributionId Value:1000780913 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…

Strategic Outsourcing Solution Provides Predictable Development Outcomes for Successful MedTech Regulatory Approval and Market Adoption TOLEDO, Ohio--(BUSINESS WIRE)--#CRO--NAMSA, a world-leading MedTech Contract Research Organization…

Collaboration leverages Tenacia’s CNS, R&D, and local market expertise to support expansion of ganaxolone’s development programs and potentially provide additional access to patients globally Marinus to receive an upfront fee of…